Choosing an animal model for the study of Huntington's disease

MA Pouladi, AJ Morton, MR Hayden - Nature Reviews Neuroscience, 2013 - nature.com
Since the identification of the causative gene in Huntington's disease (HD), a number of
animal models of this disorder have been developed. A frequently asked question is: which …

The neuropathology of Huntington's disease

HJ Waldvogel, EH Kim, LJ Tippett… - … of Huntington's disease …, 2015 - Springer
The basal ganglia are a highly interconnected set of subcortical nuclei and major atrophy in
one or more regions may have major effects on other regions of the brain. Therefore, the …

A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration

M Di Stefano, I Nascimento-Ferreira… - Cell Death & …, 2015 - nature.com
NAD metabolism regulates diverse biological processes, including ageing, circadian rhythm
and axon survival. Axons depend on the activity of the central enzyme in NAD biosynthesis …

Beyond the brain: widespread pathology in Huntington's disease

JMM van der Burg, M Björkqvist, P Brundin - The Lancet Neurology, 2009 - thelancet.com
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a
polyglutamine stretch in the huntingtin protein. Today, more than 15 years after the genetic …

Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy

S Kariya, GH Park, Y Maeno-Hikichi… - Human molecular …, 2008 - academic.oup.com
Spinal muscular atrophy (SMA) is a common pediatric neuromuscular disorder caused by
insufficient levels of the survival of motor neuron (SMN) protein. Studies involving SMA …

The S/T-rich motif in the DNAJB6 chaperone delays polyglutamine aggregation and the onset of disease in a mouse model

V Kakkar, C Månsson, EP de Mattos, S Bergink… - Molecular cell, 2016 - cell.com
Expanded CAG repeats lead to debilitating neurodegenerative disorders characterized by
aggregation of proteins with expanded polyglutamine (polyQ) tracts. The mechanism of …

Treating the whole body in Huntington's disease

JB Carroll, GP Bates, J Steffan, C Saft… - The Lancet …, 2015 - thelancet.com
Huntington's disease is a genetic neurodegenerative disorder with symptoms that are linked
to the progressive dysfunction and neuronal death in corticostriatal circuits. The causative …

Impaired PGC-1α function in muscle in Huntington's disease

RK Chaturvedi, P Adhihetty, S Shukla… - Human molecular …, 2009 - academic.oup.com
We investigated the role of PPAR γ coactivator 1α (PGC-1α) in muscle dysfunction in
Huntington's disease (HD). We observed reduced PGC-1α and target genes expression in …

Synaptic vulnerability in neurodegenerative disease

TM Wishart, SH Parson… - … of Neuropathology & …, 2006 - academic.oup.com
Recent developments in our understanding of the pathophysiological mechanisms
underlying degeneration in both the central and peripheral nervous systems have …

Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease

C Ferrari Bardile, M Garcia-Miralles… - Proceedings of the …, 2019 - National Acad Sciences
White matter abnormalities are a nearly universal pathological feature of neurodegenerative
disorders including Huntington disease (HD). A long-held assumption is that this white …